Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes with Diabetic Macular Edema in Protocol T

MLA

Lee M. Jampol, et al. Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes with Diabetic Macular Edema in Protocol T. Aug. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....527bf137fc8a3acdbc9b80874fd5fcef&authtype=sso&custid=ns315887.

APA

Lee M. Jampol, Michele Melia, Kevin J. Blinder, Neil M. Bressler, Victor H. Gonzalez, John A. Wells, Susan B. Bressler, Jennifer K. Sun, Maureen G. Maguire, Adam R. Glassman, & Wesley T. Beaulieu. (2018). Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes with Diabetic Macular Edema in Protocol T.

Chicago

Lee M. Jampol, Michele Melia, Kevin J. Blinder, Neil M. Bressler, Victor H. Gonzalez, John A. Wells, Susan B. Bressler, et al. 2018. “Early Response to Anti-Vascular Endothelial Growth Factor and Two-Year Outcomes Among Eyes with Diabetic Macular Edema in Protocol T,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....527bf137fc8a3acdbc9b80874fd5fcef&authtype=sso&custid=ns315887.